Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Revenue (2016 - 2025)

Abeona Therapeutics has reported Revenue over the past 13 years, most recently at $5.4 million for Q4 2025.

  • Quarterly results put Revenue at $5.4 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $5.8 million (changed N/A YoY), and the annual figure for FY2025 was $5.8 million, changed.
  • Revenue for Q4 2025 was $5.4 million at Abeona Therapeutics, up from $400000.0 in the prior quarter.
  • Over the last five years, Revenue for ABEO hit a ceiling of $5.4 million in Q4 2025 and a floor of -$1.5 million in Q2 2021.
  • Median Revenue over the past 4 years was $207000.0 (2022), compared with a mean of $709000.0.
  • Biggest five-year swings in Revenue: tumbled 136.67% in 2021 and later soared 250.0% in 2023.
  • Abeona Therapeutics' Revenue stood at -$48000.0 in 2021, then surged by 241.67% to $68000.0 in 2022, then soared by 5047.06% to $3.5 million in 2023, then soared by 54.86% to $5.4 million in 2025.
  • The last three reported values for Revenue were $5.4 million (Q4 2025), $400000.0 (Q2 2025), and $3.5 million (Q2 2023) per Business Quant data.